B. Cruz

Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication

S. Chung, O. Rotstein, R. Gorczynski, 1995, Journal of virology.

Entry of African swine fever virus into Vero cells and uncoating.

A. Geraldes, M. L. Valdeira, B. Cruz, 1998, Veterinary microbiology.

The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response.

R. Parkhouse, A. Leitão, J. Vigário, 2001, The Journal of general virology.

An in vitro model of hepatitis C virion production.

T. Liang, G. Luo, T. Heller, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.

R. Gorczynski, G. Levy, R. Suhadolnik, 1995, The Journal of general virology.

Bacterial lipoprotein based expression vectors as tools for the characterisation of African swine fever virus (ASFV) antigens

A. Leitão, P. Cornelis, G. Vasco, 2000, Archives of Virology.

A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.

R. Gorczynski, J. Leibowitz, E. Skamene, 1994, Immunology.